Healthcare Associated Infection
23
4
6
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.7%
2 terminated out of 23 trials
86.7%
+0.2% vs benchmark
9%
2 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (23)
Evaluation of GeoHAI Implementation
NO Prevention of COVID-19 for Healthcare Providers
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
Community-associated Highly-Resistant Enterobacterales
Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients
Evaluation of Healthcare Waste Management Practices and Problems Among Primary and Secondary Hospitals
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
Surgical Handwashing: Drying With One or Two Surgical Towels
Dynamic Full-field Optical Coherence Tomography for Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Critically Ill Patients
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Ventricular Assist Device (VAD) Infection Prevention Survey
Red Light Photobiomodulation and Topical Disinfectants
Copper Use as Protection Against Antimicrobial Resistance in the ICU
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)
Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU
Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital
Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years